Fig 1.
Interrelations between cancer, frailty, adverse outcomes and quality of life.
Fig 2.
Flowchart included TOPICS-MDS studies.
FU = Follow-up.
Table 1.
Sample characteristics of the respondents with versus without cancer.
Fig 3.
Heat map presenting the proportions of frailty deficits in frail* respondents with versus without cancer.
The proportions in frailty deficits per item among older frail people with and without cancer were graphically represented as colors. The higher the proportion, the higher the color intensity. In addition, percentages of participants with the deficit endorsed were also shown. * Cut-off point for frail people: TOPICS-FI38 ≥ 0.25.
Table 2.
Associations of baseline frailty, cancer and their interaction with CSAL score at baseline and follow-up.
Table 3.
Associations of baseline frailty, cancer and their interaction with EQ-5D score at baseline and follow-up.